Price $5.73 |
Market Cap
7.4M
|
Sector Health Care |
Div. Growth
-
|
|
P/E
-
|
P/B
0.86
|
P/S
-
|
Dividend %
-
|
|
P/CF
-
|
P/FCF
-
|
Op. Cash Flow
-8.2K
|
FCF
-0.6
|
|
Op. Margin
-
|
Net Margin
-
|
ROE
-94.60%
|
ROI
-
|
|
ROA
-83.20%
|
EPS Growth
68.30%
|
Current Ratio
8.5
|
Debt/Equity
-
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Champions Oncology Inc (CSBR) | $7.90 | - | - | 114.3M | Strong Buy |
| Celsion Corporation (CLSN) | $2.34 | - | - | 37.6M | Strong Buy |
| Lannett Company, Inc. (LCI) | $7.15 | - | - | 297M | Strong Buy |
| Infinity Pharmaceuticals Inc. (INFI) | $1.57 | - | - | 107M | Strong Buy |
| InfuSystem Holdings Inc (INFU) | $4.61 | - | - | 97.7M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
